메뉴 건너뛰기




Volumn 25, Issue 10, 2009, Pages 2401-2411

Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes

Author keywords

Dipeptidyl peptidase 4 inhibitor; Glycemic control; Incretin; Monotherapy; Saxagliptin; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HYPERGLYCEMIC AGENT; METFORMIN; PLACEBO; SAXAGLIPTIN;

EID: 70349333861     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990903178735     Document Type: Article
Times cited : (281)

References (15)
  • 1
    • 33846006173 scopus 로고    scopus 로고
    • The incretin system: Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
    • Drucker DJ, Nauck MA. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006;368:1696-1705
    • (2006) Lancet , vol.368 , pp. 1696-1705
    • Drucker, D.J.1    Nauck, M.A.2
  • 2
    • 33847685714 scopus 로고    scopus 로고
    • Dipeptidyl peptidase-4 inhibitors and the management of type 2 diabetes mellitus
    • DOI 10.1097/MED.0b013e3280a02f65, PII 0126602920070400000003
    • Rosenstock J, Zinman B. Dipeptidyl peptidase-4 inhibitors and the management of type 2 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes 2007;14:98-107 (Pubitemid 46363290)
    • (2007) Current Opinion in Endocrinology, Diabetes and Obesity , vol.14 , Issue.2 , pp. 98-107
    • Rosenstock, J.1    Zinman, B.2
  • 4
    • 34248223285 scopus 로고    scopus 로고
    • Biology of incretins: GLP-1 and GIP
    • Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007;132:2131-2157
    • (2007) Gastroenterology , vol.132 , pp. 2131-2157
    • Baggio, L.L.1    Drucker, D.J.2
  • 6
    • 33644618433 scopus 로고    scopus 로고
    • The biology of incretin hormones
    • Drucker DJ. The biology of incretin hormones. Cell Metab 2006;3:153-165
    • (2006) Cell Metab , vol.3 , pp. 153-165
    • Drucker, D.J.1
  • 7
    • 34247357752 scopus 로고    scopus 로고
    • Oral antidiabetic agents in type 2 diabetes
    • DOI 10.1185/030079907X178766
    • Levetan C. Oral antidiabetic agents in type 2 diabetes. Curr Med Res Opin 2007;23:945-952 (Pubitemid 46631497)
    • (2007) Current Medical Research and Opinion , vol.23 , Issue.4 , pp. 945-952
    • Levetan, C.1
  • 8
    • 42149194313 scopus 로고    scopus 로고
    • Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes
    • Rosenstock J, Sankoh S, List JF. Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes. Diabetes Obes Metab 2008;10:376-386
    • (2008) Diabetes Obes Metab , vol.10 , pp. 376-386
    • Rosenstock, J.1    Sankoh, S.2    List, J.F.3
  • 9
    • 0021813187 scopus 로고
    • Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
    • DOI 10.1007/BF00280883
    • Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419 (Pubitemid 15018832)
    • (1985) Diabetologia , vol.28 , Issue.7 , pp. 412-419
    • Matthews, D.R.1    Hosker, J.P.2    Rudenski, A.S.3
  • 10
    • 0032821965 scopus 로고    scopus 로고
    • Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp
    • DOI 10.2337/diacare.22.9.1462
    • Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-1470 (Pubitemid 29418240)
    • (1999) Diabetes Care , vol.22 , Issue.9 , pp. 1462-1470
    • Matsuda, M.1    Defronzo, R.A.2
  • 11
    • 0035089445 scopus 로고    scopus 로고
    • A model-based method for assessing insulin sensitivity from the oral glucose tolerance test
    • Mari A, Pacini G, Murphy E, et al. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 2001;24:539-548 (Pubitemid 32198427)
    • (2001) Diabetes Care , vol.24 , Issue.3 , pp. 539-548
    • Mari, A.1    Pacini, G.2    Murphy, E.3    Ludvik, B.4    Nolan, J.J.5
  • 12
    • 48149095259 scopus 로고    scopus 로고
    • Translating the A1C assay into estimated average glucose values
    • Nathan DM, Kuenen J, Borg R, et al. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008;31:1473-1478
    • (2008) Diabetes Care , vol.31 , pp. 1473-1478
    • Nathan, D.M.1    Kuenen, J.2    Borg, R.3
  • 13
    • 33845472504 scopus 로고    scopus 로고
    • Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes
    • DOI 10.2337/dc06-0703
    • Aschner P, Kipnes MS, Lunceford JK, et al. Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care 2006;29:2632-2637 (Pubitemid 44912190)
    • (2006) Diabetes Care , vol.29 , Issue.12 , pp. 2632-2637
    • Aschner, P.1    Kipnes, M.S.2    Lunceford, J.K.3    Sanchez, M.4    Mickel, C.5    Williams-Herman, D.E.6
  • 14
    • 55449096196 scopus 로고    scopus 로고
    • Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: A model-based approach
    • Xu L, Man CD, Charbonnel B, et al. Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: a model-based approach. Diabetes Obes Metab 2008;10:1212-1220
    • (2008) Diabetes Obes Metab , vol.10 , pp. 1212-1220
    • Xu, L.1    Man, C.D.2    Charbonnel, B.3
  • 15
    • 52249090472 scopus 로고    scopus 로고
    • Robust improvements in fasting and prandial measures of β-cell function with vildagliptin in drug-naïve patients: Analysis of pooled vildagliptin monotherapy database
    • Pratley RE, Schweizer A, Rosenstock J, et al. Robust improvements in fasting and prandial measures of β-cell function with vildagliptin in drug-naïve patients: analysis of pooled vildagliptin monotherapy database. Diabetes Obes Metab 2008;10:931-938
    • (2008) Diabetes Obes Metab , vol.10 , pp. 931-938
    • Pratley, R.E.1    Schweizer, A.2    Rosenstock, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.